Michelle Dow

Michelle Dow is currently an Associate Principal Scientist at Merck, specializing in computational biology and the analysis of NGS multi-omic data. With prior experience as a Computational Genomics Research Scientist I at Vertex Pharmaceuticals, Michelle’s research has focused on the impact of genetic variation on gene function relating to anti-cancer drug responses. Michelle also held various roles in academic settings, including a Graduate Student Researcher at the University of California, San Diego and a Student Coordinator at the University of British Columbia. Educated at the University of California, San Diego, Michelle has contributed to advancing the understanding of tumor-immune interactions and therapeutic responses.